We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By closing this message, you are consenting to our use of cookies.

CARDIOVASCULAR

Taylor & Francis are delighted to announce our partnership with the West Cardiometabolic Health Congress (CMHC)

Registrations to attend this year's event are now open!

CMHC Presents Evolving Paradigms in Cardiometabolic Care: Disparities & Advancements

This October, the Cardiometabolic Health Congress will be hosting the 15th Annual CMHC Live Online: Evolving Paradigms in Cardiometabolic Care: Disparities & Advancements. For the first time in its 15 year span, CMHC will deliver this esteemed annual event entirely online. Led by leading clinical experts this conference will present the latest information and updates across the cardiometabolic healthcare industry as well as provide a deep dive into the intersection of social determinants of health and cardiometabolic care through an interactive and easy-to-navigate online format.

The event will begin with an in-depth pre-conference centered titled: Impact of Ethnicity and Race in Cardiometabolic Health. Participants will engage in lectures and discussions on issues such as counseling patients living in food deserts, combination medications in racially marginalized groups, navigating healthcare costs, culturally informed treatment strategies and more. Led by a panel of clinical leaders at the intersection of race and cardiometabolic care, this offering will help participants build a practical strategy through which to effectively navigate the pervasive challenges of inequity in healthcare.

The remaining three days of the conference will provide expert coverage on the latest guidance, updates, and scientific knowledge in advanced cardiometabolic care. On Thursday, Dr. Eugene Braunwald, MD--the Distinguished Hersey Professor of Medicine at Harvard Medical School, and the founding Chair of the TIMI Study Group at the Brigham and Women’s Hospital-- will present his keynote address: Evolving Paradigms in Cardiovascular Research and Care: Reflections and Perspectives. The remainder of the day will cover the latest FDA updates, late-breaking trials, and a full in-depth session on hypertension, heart failure, and the kidney. Day three of the conference will be split into two sessions: one covering dyslipidemia, atherosclerosis, and thrombosis, and the other providing an expert’s perspective on new diabetes updates and guidelines. On the final day of the conference, participants will analyze the latest in obesity and lifestyle management.

Developed and led by leading clinicians, researchers, industry thought leaders, and more, this online educational event will provide practitioners with top-tier clinical education and actionable insights all from the setting of their choosing. Designed as a direct response to the real-world clinical needs of active practitioners and patients, the 15th Annual Cardiometabolic Health Congress will deliver the most valuable scientific knowledge and late-breaking updates through a clinically equitable lens.

At Taylor & Francis we proud ourselves in publishing high impact journals delivering quality information to the global cardiovascular research community. Read on for more information on our journals as well as the different publishing options we offer.

Looking to publish your research?

Get in touch with one of our expert editors to discuss your work or visit our dedicated author services site filled with information to support you through the publication process.

 


 

 

Expert Review of Cardiovascular Therapy

 

 

Expert Review of Medical Devices

IF: 2.200

 

 

Scandinavian Cardiovascular Journal

IF: 1.084

 

 

Acta Cardiologica

IF: 1.208

 

 

 

Blood Pressure

IF: 2.169

 

 

Postgraduate Medicine

IF: 2.464

Open Access

Why publish Open Access?

Open Access provides you with the following great benefits:

  • Immediate access to your article on publication, accessible by anyone, anywhere
  • High visibility and discoverability via Taylor & Francis Online
  • Input from, and dialog with, expert editors
  • Rigorous peer review for every open access article
  • Metrics (downloads, citations, and Altmetric data) for your article, so you can measure its impact

Want to know more about Open Access? 

Find out more

Accelerated Publication

If time is critical in your publishing strategy, our Accelerated Publication options can help you get your research into a high-quality, peer-reviewed journal, fast.

Accelerated Publication allows you to:

  • coordinate your publishing schedule with conferences, drug approvals, and drug launches,
  • keep competitive advantage by getting your discoveries to market quickly,
  • and speed up the peer review process without sacrificing quality or rigour.

Find out more

Latest Tweets